C116H172BrI4N19O19 — CID 159509108
5-bromo-2-[4-(cyclohexylamino)piperidin-1-yl]-N-methylpyridine-3-carboxamide;3-O-ethyl 5-O-methyl 2-[4-(cyclohexylamino)piperidin-1-yl]-6-methylpyridine-3,5-dicarboxylate;methyl 2-[4-(cyclopentylamino)-3-(hydroxymethyl)piperidin-1-yl]-5-iodopyridine-3-carboxylate;methyl 2-[3-(hydroxymethyl)-4-[(2-methoxycyclohexyl)amino]piperidin-1-yl]-5-iodopyridine-3-carboxylate;methyl 2-[3-(hydroxymethyl)-4-[(2-methylcyclohexyl)amino]piperidin-1-yl]-5-iodopyridine-3-carboxylate;methyl 2-[3-(hydroxymethyl)-4-(oxan-4-ylamino)piperidin-1-yl]-5-iodopyridine-3-carboxylate (PubChem CID 159509108) has the molecular formula C116H172BrI4N19O19 and a molecular weight of 2724.29 g/mol. Its IUPAC name is 5-bromo-2-[4-(cyclohexylamino)piperidin-1-yl]-N-methylpyridine-3-carboxamide;3-O-ethyl 5-O-methyl 2-[4-(cyclohexylamino)piperidin-1-yl]-6-methylpyridine-3,5-dicarboxylate;methyl 2-[4-(cyclopentylamino)-3-(hydroxymethyl)piperidin-1-yl]-5-iodopyridine-3-carboxylate;methyl 2-[3-(hydroxymethyl)-4-[(2-methoxycyclohexyl)amino]piperidin-1-yl]-5-iodopyridine-3-carboxylate;methyl 2-[3-(hydroxymethyl)-4-[(2-methylcyclohexyl)amino]piperidin-1-yl]-5-iodopyridine-3-carboxylate;methyl 2-[3-(hydroxymethyl)-4-(oxan-4-ylamino)piperidin-1-yl]-5-iodopyridine-3-carboxylate.
| Compound Name | 5-bromo-2-[4-(cyclohexylamino)piperidin-1-yl]-N-methylpyridine-3-carboxamide;3-O-ethyl 5-O-methyl 2-[4-(cyclohexylamino)piperidin-1-yl]-6-methylpyridine-3,5-dicarboxylate;methyl 2-[4-(cyclopentylamino)-3-(hydroxymethyl)piperidin-1-yl]-5-iodopyridine-3-carboxylate;methyl 2-[3-(hydroxymethyl)-4-[(2-methoxycyclohexyl)amino]piperidin-1-yl]-5-iodopyridine-3-carboxylate;methyl 2-[3-(hydroxymethyl)-4-[(2-methylcyclohexyl)amino]piperidin-1-yl]-5-iodopyridine-3-carboxylate;methyl 2-[3-(hydroxymethyl)-4-(oxan-4-ylamino)piperidin-1-yl]-5-iodopyridine-3-carboxylate |
|---|---|
| PubChem CID | 159509108 |
| Molecular Formula | C116H172BrI4N19O19 |
| Molecular Weight | 2724.29 g/mol |
| Exact Mass | 2721.84 |
| IUPAC Name | 5-bromo-2-[4-(cyclohexylamino)piperidin-1-yl]-N-methylpyridine-3-carboxamide;3-O-ethyl 5-O-methyl 2-[4-(cyclohexylamino)piperidin-1-yl]-6-methylpyridine-3,5-dicarboxylate;methyl 2-[4-(cyclopentylamino)-3-(hydroxymethyl)piperidin-1-yl]-5-iodopyridine-3-carboxylate;methyl 2-[3-(hydroxymethyl)-4-[(2-methoxycyclohexyl)amino]piperidin-1-yl]-5-iodopyridine-3-carboxylate;methyl 2-[3-(hydroxymethyl)-4-[(2-methylcyclohexyl)amino]piperidin-1-yl]-5-iodopyridine-3-carboxylate;methyl 2-[3-(hydroxymethyl)-4-(oxan-4-ylamino)piperidin-1-yl]-5-iodopyridine-3-carboxylate |
| SMILES | CCOC(=O)c1cc(C(=O)OC)c(C)nc1N1CCC(NC2CCCCC2)CC1.CNC(=O)c1cc(Br)cnc1N1CCC(NC2CCCCC2)CC1.COC(=O)c1cc(I)cnc1N1CCC(NC2CCCC2)C(CO)C1.COC(=O)c1cc(I)cnc1N1CCC(NC2CCCCC2C)C(CO)C1.COC(=O)c1cc(I)cnc1N1CCC(NC2CCCCC2OC)C(CO)C1.COC(=O)c1cc(I)cnc1N1CCC(NC2CCOCC2)C(CO)C1 |
| InChI | InChI=1S/C22H33N3O4.C20H30IN3O4.C20H30IN3O3.C18H27BrN4O.C18H26IN3O4.C18H26IN3O3/c1-4-29-22(27)19-14-18(21(26)28-3)15(2)23-20(19)25-12-10-17(11-13-25)24-16-8-6-5-7-9-16;1-27-18-6-4-3-5-17(18)23-16-7-8-24(11-13(16)12-25)19-15(20(26)28-2)9-14(21)10-22-19;1-13-5-3-4-6-17(13)23-18-7-8-24(11-14(18)12-25)19-16(20(26)27-2)9-15(21)10-22-19;1-20-18(24)16-11-13(19)12-21-17(16)23-9-7-15(8-10-23)22-14-5-3-2-4-6-14;1-25-18(24)15-8-13(19)9-20-17(15)22-5-2-16(12(10-22)11-23)21-14-3-6-26-7-4-14;1-25-18(24)15-8-13(19)9-20-17(15)22-7-6-16(12(10-22)11-23)21-14-4-2-3-5-14/h14,16-17,24H,4-13H2,1-3H3;9-10,13,16-18,23,25H,3-8,11-12H2,1-2H3;9-10,13-14,17-18,23,25H,3-8,11-12H2,1-2H3;11-12,14-15,22H,2-10H2,1H3,(H,20,24);8-9,12,14,16,21,23H,2-7,10-11H2,1H3;8-9,12,14,16,21,23H,2-7,10-11H2,1H3 |
| InChIKey | MAJJTQMHRSMFOE-UHFFFAOYSA-N |
| XLogP | 15.00 |
| TPSA | 455.24 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 37 |
| Rotatable Bonds | 31 |
| Heavy Atoms | 159 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2724.29 |
| LogP ≤ 5 | 15.00 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 37 |
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'} |
|---|